Aller au contenu

Impact of disease evolution on efficacy outcomes from larotrectinib in patients with locally advanced or metastatic tropomyosin receptor Kinase fusion-positive solid tumors

Nom du journal : JCO Precis Oncol

Année : 2021

Volume : 5

Page de départ : PO.21.00089

Auteurs: Italiano A, Vassal G, Bokemeyer C, De La Cuesta E, Hiemeyer F, Fellous M, Marian M,